Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
Transcesarean IUD Insertion: A Prospective Cohort Study
1 other identifier
interventional
90
1 country
2
Brief Summary
The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Aug 2008
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 21, 2011
CompletedFirst Posted
Study publicly available on registry
September 23, 2011
CompletedResults Posted
Study results publicly available
December 29, 2022
CompletedApril 7, 2023
April 1, 2023
1.3 years
September 21, 2011
October 31, 2022
April 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Expulsion of IUD
Number of participants with Expulsion of IUDs placed at time of cesarean delivery.
6 week postpartum
Secondary Outcomes (2)
Satisfaction of IUD Placement
6 months postpartum
Number of Participants With Expulsion of IUD
6 months postpartum
Interventions
Placement of Paragard IUD at time of Cesarean Delivery
Eligibility Criteria
You may qualify if:
- singleton gestation
- greater than 35 weeks gestation
- speaks English or Spanish
- desires IUD for contraception
- undergoing a cesarean delivery
You may not qualify if:
- evidence of chorioamnionitis
- history of chlamydia within this pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Jacobi Medical Center
The Bronx, New York, 10461, United States
Montefiore Medical Center, Weiler Division
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Erika Levi
- Organization
- Albert Einstein College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Amitasrigowri Murthy, MD
NYU School of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2011
First Posted
September 23, 2011
Study Start
August 1, 2008
Primary Completion
November 1, 2009
Study Completion
May 1, 2010
Last Updated
April 7, 2023
Results First Posted
December 29, 2022
Record last verified: 2023-04